FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056897 [Registered on: 24/08/2023] Trial Registered Prospectively
Last Modified On: 16/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To understand the efficacy of Mallotus nudiflorus (L.) (traditionally used substitute of Gambhari) and Gambhari (Gmelina arborea roxb.) in the patients of Sotha( General oedema) 
Scientific Title of Study   Evaluation of Mallotus nudiflorus (L.) Kulju & Welzen as an alternative to one of the Dashamoola plant Gambhari (Gmelina arborea Roxb) 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vijayalekshmi R 
Designation  Ph.D Scholar 
Affiliation  institute of teaching and research in Ayurveda, Jamnagar  
Address  3rd floor, Department of Dravyaguna, institute of teaching and research in Ayurveda, Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  09567996480  
Fax    
Email  lekshmivijaya992@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Bhupesh R Patel 
Designation  Associate Professor  
Affiliation  Institute of teaching and research in Ayurveda , Jamnagar 
Address  329, Department of Dravyaguna, Institute of teaching and research in Ayurveda , Jamnagar- 361008

Jamnagar
GUJARAT
361008
India 
Phone  7487876343  
Fax    
Email  brpayu@itra.edu.in  
 
Details of Contact Person
Public Query
 
Name  Vijayalekshmi R 
Designation  Ph.D Scholar 
Affiliation  institute of teaching and research in Ayurveda, Jamnagar 
Address  3rd floor, Department of Dravyaguna, institute of teaching and research in Ayurveda, Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  09567996480  
Fax    
Email  lekshmivijaya992@gmail.com  
 
Source of Monetary or Material Support  
Institute of Teaching and Research in Ayurveda  
 
Primary Sponsor  
Name  ITRA Hospital  
Address  Institute of Teaching and Research in Ayurveda, Opposite Reliance Mart,Jamnagar-361008 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vijaya Lekshmi R  ITRA Hospital  OPD NO.10,Department Of Dravyaguna, Institute of Teaching and Research in Ayurveda, Opposite Reliance mart,Jamnagar-361008
Jamnagar
GUJARAT 
9567996480

lekshmivijaya992@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Institute of Teaching and Research in Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:R601||Generalized edema. Ayurveda Condition: SOTHAH, (2) ICD-10 Condition:R601||Generalized edema. Ayurveda Condition: SVAYATHUH/SOTHAH/SOPAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Mallotus nudiflorus (L.) Kulju & Welzen , Reference: NA, Route: Oral, Dosage Form: Kwatha/Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Weeks, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Gambhari (Gmelina arborea Roxb), Reference: Bhavprakash Nighantu, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Weeks, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1.Patients presenting with the classical signs and symptoms of Shotha with less than 3 months of
chronicity except Paittika Shotha and inflammatory swellings due to Abhighata or other causes
2.Patients of will be selected irrespective of sex,religion etc
3.Patients aged between 25-75 years 
 
ExclusionCriteria 
Details  1.Patients suffering from any systemic uncontrolled disease-like Diabetes(>180mg/dl), Hyper tension
(>160/100mm of Hg), Cardiac anomaly, Chronic renal failure, Liver cirrhosis, filariasis etc.
2.Pregnant or lactating mother
3.Patients exhibiting lakshanas of Paittika Shotha and inflammatory swellings due to Abhighata or
other causes.
4.Patients suffering from any auto immune diseases. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in condition will be assessed on the basis of changes in scoring patterns and measurements of affected parts   Changes in the Signs and Symptoms with measurements of affected parts will be assessed on zero and 14th day. 
 
Secondary Outcome  
Outcome  TimePoints 
Change in routine Biochemistry, Blood & Urine investigations on 0th and 14th day  zero & 14th day 
changes in routine Biochemistry, Blood & Urine Investigation before & after treatment  zero & 14th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This trial is randomized clinical trial to evaluate the efficacy of Mallotus nudiflorus (L.) in comparison to Gambhari (Gmelina arborea Roxb) in the management of Sotha. total 30 patients will be enrolled in the study. Selected patients will be divided into two groups on the basis of computer-generated randomization. in this study group A will be given Kwath of stem bark of Mallotus nudiflorus (50 ml twice a day after food ) for two weeks. and in Group B kwatha of stem bark of Gambhari (Gmelina arborea Roxb) (50 ml twice a day after food ) for two weeks.  
Close